Purpose: To evaluate the efficacy of topical cyclosporin A 0.05% in the management of severe allergic conjunctivitis.
Methods: Seven patients with severe allergic conjunctivitis who were not responding to topical steroids, antihistamines, and mast cell stabilizers were given topical cyclosporin A 0.